Latest Breaking News On - Craig granowitz - Page 12 : comparemela.com

Lexicon Pharmaceuticals, Inc (LXRX) Q3 2022 Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:LXRX) Q3 2022 Earnings Conference Call November 09, 2022 5:00 PM ET Company Participants Mike Kelly – Investor Relations Lonnel Coats – Chief.

United statesDistrict of columbiaCraig granowitzPiper sandlerJeff wadeCarly kenselaarYasmeen rahimiMike kellyBertram pittYigal nochomovitzCompany participantsLexicon pharmaceuticalsJoseph stringer of needham companyAmerican heart association scientific sessionsLexicon pharmaceuticals incExchange commission

New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure

New Analysis of SOLOIST-WHF Results Demonstrates Sotagliflozin s Significant Effect in Reducing the Risk of Hospital Readmissions for Heart Failure
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCraig granowitzBertram pittSchool of medicineLexicon pharmaceuticalsMike kellylexicon pharmaceuticals incAmerican heart association scientific sessionsLexicon pharmaceuticals incUniversity of michiganExchange commissionAlina kolomeyerlexicon pharmaceuticals incScience session of the american heart associationWall streetHeart failureFrom benchLate breaking science session

Lexicon Pharma (LXRX) Presents New Strong Analysis of Sotagliflozin

Lexicon Pharma (LXRX) Presents New Strong Analysis of Sotagliflozin
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCraig granowitzBertram pittSchool of medicineAmerican heart association scientific sessionsLexicon pharmaceuticals incUniversity of michiganWall streetHeart failureFrom bench

New Analysis of SCORED Trial Demonstrates Sotagliflozins Effect on Reducing Albuminuria in Patients with Type 2 Diabetes and Chronic Kidney Disease

Post hoc analysis of clinical data from the SCORED trial presented at the American Society of Nephrology Kidney Week 2022 annual scientific meeting, including evidence that:

United statesCraig granowitzDavid zi cherneyLexicon pharmaceuticalsSteering committeeLexicon pharmaceuticals incScience session of the american heart associationUniversity of torontoAmerican society of nephrology kidney weekDepartment of medicineAmerican societyNephrology kidney weekLate breaking science sessionAmerican heart associationScientific sessionsNew england journal

New Analysis of SOLOIST-WHF Results Demonstrates

Risk Reductions of 46% to 52% for Heart Failure Readmissions and for Composite of CV Death and Heart Failure Readmissions at 30 and 90 Days Following.

United statesCraig granowitzMike kellyBertram pittSchool of medicineLexicon pharmaceuticalsAmerican heart association scientific sessionsLexicon pharmaceuticals incUniversity of michiganScience session of the american heart associationExchange commissionHeart failureFrom benchLate breaking science sessionAmerican heart associationScientific sessions